{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-027758","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2023-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.741107+00:00","generated_at":"2026-06-14T02:05:39.606685+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Treace Medical completes $20M acquisition of RedPoint Medical3D's PSI assets","bullets":["Paid $20M cash at closing for RPM-3D assets used in pre-op planning and patient-specific guides for bunion surgery.","Earnout up to $10M: $3.5M for transition services, $3.5M for tech milestones, up to $3M upon patent issuance.","RPM-3D software integration with Lapiplasty system planned for 2023; commercial launch expected H2 2024.","CEO says acquisition adds FDA-cleared PSI technologies, expanding customization for Lapiplasty and Adductoplasty.","Entered non-compete/non-solicitation agreements with RPM-3D and consulting agreements with Dr. Adam Perler and James Spitler."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-027758","json":"https://secwatch.observer/filing/0000950170-23-027758.json","markdown":"https://secwatch.observer/filing/0000950170-23-027758.md","text":"https://secwatch.observer/filing/0000950170-23-027758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/0000950170-23-027758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/tmci-20230612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T02:05:39.606685+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c8e438cb9c4a78ef83f13cf044ea243bec6cc53","claim":"TREACE MEDICAL CONCEPTS, INC. completed an acquisition involving MIOS Marketing, LLC d/b/a RedPoint Medical3d (\"RPM-3D\") for $20.0 million (closed 2023-06-12).","evidence_excerpt":"of RPM-3D. On June 12, 2023, the Company completed its acquisition of certain assets of RPM-3D pursuant to the APA. In accordance with the APA, at closing, TMCI paid RPM-3D $20.0 million in exchange for RPM-3D’s assets used in providing pre-operative planning and patient-specific guides for the surgical correction of foot and ankle deformities. Under the APA,","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/0000950170-23-027758-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"MIOS Marketing, LLC d/b/a RedPoint Medical3d (\"RPM-3D\")"},{"label":"Consideration","value":"$20.0 million"},{"label":"Closing","value":"2023-06-12"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}